Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 9 studies | 24% ± 6% | |
peripheral blood | 9 studies | 21% ± 7% | |
brain | 9 studies | 32% ± 13% | |
kidney | 5 studies | 17% ± 1% | |
bone marrow | 4 studies | 20% ± 6% | |
intestine | 3 studies | 24% ± 10% | |
adipose | 3 studies | 21% ± 4% | |
liver | 3 studies | 34% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7785.97 | 1445 / 1445 | 100% | 123.21 | 183 / 183 |
lung | 100% | 9060.19 | 578 / 578 | 100% | 104.45 | 1155 / 1155 |
ovary | 100% | 9724.60 | 180 / 180 | 100% | 98.82 | 430 / 430 |
breast | 100% | 10221.14 | 459 / 459 | 100% | 167.89 | 1117 / 1118 |
intestine | 100% | 8189.10 | 966 / 966 | 100% | 109.33 | 526 / 527 |
uterus | 100% | 9332.26 | 170 / 170 | 100% | 88.83 | 458 / 459 |
brain | 100% | 7316.15 | 2636 / 2642 | 100% | 106.49 | 705 / 705 |
bladder | 100% | 9042.67 | 21 / 21 | 100% | 90.41 | 502 / 504 |
prostate | 100% | 8061.98 | 245 / 245 | 100% | 98.64 | 500 / 502 |
stomach | 100% | 6338.62 | 359 / 359 | 99% | 113.35 | 284 / 286 |
thymus | 100% | 8364.00 | 653 / 653 | 99% | 84.53 | 600 / 605 |
pancreas | 100% | 5336.83 | 327 / 328 | 99% | 76.74 | 177 / 178 |
skin | 100% | 12072.42 | 1808 / 1809 | 99% | 114.36 | 467 / 472 |
kidney | 100% | 7630.81 | 89 / 89 | 97% | 72.91 | 873 / 901 |
adrenal gland | 100% | 8246.51 | 258 / 258 | 91% | 49.15 | 210 / 230 |
liver | 100% | 3470.94 | 226 / 226 | 90% | 39.87 | 366 / 406 |
adipose | 100% | 10174.98 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 8989.56 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 83.86 | 29 / 29 |
muscle | 100% | 5556.36 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6904.83 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 94.09 | 45 / 45 |
eye | 0% | 0 | 0 / 0 | 99% | 91.59 | 79 / 80 |
heart | 96% | 5479.07 | 830 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 93% | 7459.07 | 863 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0140694 | Biological process | non-membrane-bounded organelle assembly |
GO_0061003 | Biological process | positive regulation of dendritic spine morphogenesis |
GO_0062029 | Biological process | positive regulation of stress granule assembly |
GO_0048699 | Biological process | generation of neurons |
GO_0050775 | Biological process | positive regulation of dendrite morphogenesis |
GO_0106288 | Biological process | regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA |
GO_0008298 | Biological process | intracellular mRNA localization |
GO_0007416 | Biological process | synapse assembly |
GO_0017148 | Biological process | negative regulation of translation |
GO_0016020 | Cellular component | membrane |
GO_0031252 | Cellular component | cell leading edge |
GO_0030425 | Cellular component | dendrite |
GO_0000932 | Cellular component | P-body |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0043232 | Cellular component | intracellular non-membrane-bounded organelle |
GO_0005737 | Cellular component | cytoplasm |
GO_0030027 | Cellular component | lamellipodium |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0140677 | Molecular function | molecular function activator activity |
GO_0003729 | Molecular function | mRNA binding |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0140693 | Molecular function | molecular condensate scaffold activity |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CAPRIN1 |
Protein name | Cell cycle associated protein 1 (GPI-anchored membrane protein 1, isoform CRA_d) Cell cycle associated protein 1 Caprin-1 (Cell cycle-associated protein 1) (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored membrane protein 1) (GPI-anchored protein p137) (GPI-p137) (p137GPI) (Membrane component chromosome 11 surface marker 1) (RNA granule protein 105) |
Synonyms | GPIAP1 hCG_27570 RNG105 M11S1 GPIP137 |
Description | FUNCTION: mRNA-binding protein that acts as a regulator of mRNAs transport, translation and/or stability, and which is involved in synaptic plasticity in neurons and cell proliferation and migration in multiple cell types . Acts as an mRNA regulator by mediating formation of some phase-separated membraneless compartment: undergoes liquid-liquid phase separation upon binding to target mRNAs, leading to assemble mRNAs into cytoplasmic ribonucleoprotein granules that concentrate mRNAs with associated regulatory factors . Undergoes liquid-liquid phase separation following phosphorylation and interaction with FMR1, promoting formation of cytoplasmic ribonucleoprotein granules that concentrate mRNAs with factors that inhibit translation and mediate deadenylation of target mRNAs . In these cytoplasmic ribonucleoprotein granules, CAPRIN1 mediates recruitment of CNOT7 deadenylase, leading to mRNA deadenylation and degradation . Binds directly and selectively to MYC and CCND2 mRNAs . In neuronal cells, directly binds to several mRNAs associated with RNA granules, including BDNF, CAMK2A, CREB1, MAP2, NTRK2 mRNAs, as well as to GRIN1 and KPNB1 mRNAs, but not to rRNAs . . |
Accessions | ENST00000530820.5 [Q14444-2] ENST00000532820.5 [Q14444-1] G3V153 ENST00000389645.7 [Q14444-2] ENST00000534825.5 E9PLA9 ENST00000529307.1 Q14444 ENST00000341394.9 [Q14444-1] |